Pinnacle 21 By Certara

Pinnacle 21 was acquired by Certara in 2021, which formed the center of the Certara Data Sciences platform for life sciences companies. Our platform extends from PK/PD modeling and statistical analysis to medical writing and publishing. Pinnacle 21 is the global leader in leveraging clean data for informed decision-making, including preparing study data for regulatory submission. Our flagship product, Pinnacle 21 Enterprise, enables our clients to validate data quality and compliance with CDISC standards, creating a smooth data pipeline from Data Management and Biostatistics teams to health authorities such as the FDA, PMDA, and NMPA. Streamlined approvals bring life-saving medicines to patients faster.